Sex Hormone Dependency of Diethylnitrosamine‐induced Liver Tumors in Mice and Chemoprevention by Leuprorelin

The prevalence of liver tumors throughout the world makes it imperative to seek chemopreventive agents. This tumor appears to be hormone‐responsive and hormonal manipulations may therefore be beneficial. On this basis, both sexes of 12‐day‐old B6C3FJ mice were injected i.p. with diethylnitrosamine (DEN) at the dose of 2.5 μg/g body weight and observed for 32 weeks (males) or 36 weeks (females). In 100% of male mice, liver tumors were observed with an average diameter of 2.72 mm and multiplicity of 60.8. Orchidectomy at 6 weeks of age in these mice inhibited the incidence, multiplicity and size to 63%, 5.6 and 1.54 mm, respectively. By further implantation with an E2 pellet at monthly intervals, these parameters were reduced to 26%, 0.6 and 0.61 mm, respectively. Administration of a gonadotropin‐blocking chemical, leuprorelin, to DEN‐treated male mice significantly reduced the multiplicity and size of tumors to 18.3 and 2.54 mm (P<0.01 compared to those of DEN only). In female mice, the incidence of liver tumor was significantly smaller than that of males. However, ovariectomy and/or testosterone supplement significantly increased the occurrence of liver tumor. An anti‐estrogen, toremifene, caused a marked further decrease of liver tumors. Mitotic indices with bromodeoxyuridine in tumor tissues paralleled the occurrence of liver tumors. Serum testosterone levels were significantly reduced by orchidectomy or by leuprorelin administration. These results further confirm that liver tumor is testosterone‐responsive and hormonal manipulation by surgical orchidectomy or by chemical orchidectomy i.e. by leuprorelin, could substantially prevent the appearance of liver tumors.

[1]  J. Miller,et al.  Quantitative analysis of the time-dependent development of glucose-6-phosphatase-deficient foci in the livers of mice treated neonatally with diethylnitrosamine. , 1981, Cancer research.

[2]  N. Drinkwater,et al.  The androgen receptor and liver tumor development in mice. , 1990, Progress in clinical and biological research.

[3]  J. Gustafsson,et al.  On the obligatory role of the hypophysis in sexual differentiation hepatic metabolism in rats. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[4]  Hiromitsu Watanabe,et al.  Significance of Strain and Sex Differences in the Development of 252Cf Neutron‐induced Liver Tumors in Mice , 1992, Japanese journal of cancer research : Gann.

[5]  D. Jocham Leuprorelin Three-Month Depot in the Treatment of Advanced and Metastatic Prostate Cancer: Long-Term Follow-Up Results , 1998, Urologia Internationalis.

[6]  Chien-Jen Chen,et al.  Epidemiological characteristics and risk factors of hepatocellular carcinoma , 1997, Journal of gastroenterology and hepatology.

[7]  T. Goldsworthy,et al.  Loss of tumor-promoting activity of unleaded gasoline in N-nitrosodiethylamine-initiated ovariectomized B6C3F1 mouse liver. , 1997, Carcinogenesis.

[8]  D. V. van Thiel,et al.  Hormonal manipulation of human hepatocellular carcinoma. A clinical investigative and therapeutic opportunity. , 1990, Journal of hepatology.

[9]  K. Rao,et al.  Relevance of basophilic foci to promoting effect of sex hormones on hepatocarcinogenesis. , 1982, Carcinogenesis; a comprehensive survey.

[10]  W. White,et al.  Regression of rat mammary tumors effected by a gonadoliberin analog. , 1976, Cancer research.

[11]  S. Mishkin,et al.  The effect of several sex steroid hormones on the growth rate of three morris hepatoma tumor lines , 1989, Hepatology.

[12]  M. D. Reuber Importance of Testes in Induction of Hyperplastic Nodules, Carcinomas, and Cirrhosis of Liver in A × C Male Rats Ingesting 0.025% N-2-Fluorenyldiacetamide , 1974 .

[13]  H. Shinozuka,et al.  Sex steroid metabolism and receptor status in hepatic hyperplasia and cancer in rats. , 1996, Gastroenterology.

[14]  J. Ward,et al.  Evaluation of hepatocellular neoplasms in mice. , 1978, Journal of the National Cancer Institute.

[15]  M. Zerbib,et al.  [Effectiveness and tolerance of three month sustained release leuprorelin in the treatment of metastatic prostatic cancer (comparative, randomized, multicentric study]. , 1997, Progres en urologie : journal de l'Association francaise d'urologie et de la Societe francaise d'urologie.

[16]  N. Nagasue,et al.  Heterogeneity in androgen receptor levels and growth response to dihydrotestosterone in sublines derived from human hepatocellular carcinoma line (KYN-1). , 2008, Liver.

[17]  L. Yin,et al.  Influence of hypophysectomy on the biochemical effects and metabolism of aflatoxin B1 in rats. , 1973, Journal of the National Cancer Institute.

[18]  M. Vaubourdolle,et al.  Effect of D‐tryptophan‐6‐luteinizing hormone‐releasing hormone on the tumoral growth and plasma sex steroid levels in cirrhotic patients with hepatocellular carcinoma , 1989, Hepatology.

[19]  T. Ando,et al.  Leuprolide acetate prevents toxic effects of cisplatin on the kidneys and gastrointestinal tract. , 1995, Endocrine journal.

[20]  W. H. Butler,et al.  Aflatoxin carcinogenesis: Inhibition of liver cancer induction in hypophysectomized rats , 1969, International journal of cancer.

[21]  J. Whang‐Peng,et al.  Phase II study of flutamide in the treatment of hepatocellular carcinoma , 1996, Cancer.

[22]  N. Drinkwater,et al.  Genetic variation in liver tumor susceptibility, plasma testosterone levels, and androgen receptor binding in six inbred strains of mice. , 1989, Cancer research.

[23]  T. Yashiki,et al.  Regression of rat mammary tumors by a potent luteinizing hormone-releasing hormone analogue (leuprolide) administered vaginally. , 1983, Cancer research.

[24]  N. Nagasue,et al.  Androgen and estrogen receptors in hepatocellular carcinoma and the surrounding liver in women , 1989, Cancer.

[25]  J. Korula,et al.  Failure of ketoconazole as anti-androgen therapy in nonresectable primary hepatocellular carcinoma. , 1988, Journal of clinical gastroenterology.

[26]  A. Yoshiki,et al.  Strain specific sensitivity to diethylnitrosamine-induced carcinogenesis is maintained in hepatocytes of C3H/HeN⇔C57BL/6N chimeric mice , 1991 .

[27]  A. Forbes,et al.  Response to cyproterone acetate treatment in primary hepatocellular carcinoma is related to fall in free 5 alpha-dihydrotestosterone. , 1987, European journal of cancer & clinical oncology.

[28]  N. Nagasue,et al.  Effects of castration and androgen replacement on tumour growth of human hepatocellular carcinoma in nude mice. , 1996, Journal of hepatology.

[29]  K. Rao,et al.  Modifying role of partial hepatectomy and gonadectomy in ethylnitrosourea-induced hepatocarcinogenesis. , 1980, Cancer research.